Recent studies have demonstrated that FOXM1 overexpressed in gastric cancer and that elevated FOXM1 promoted tumour development in various kinds of cancers, correlated closely with poor outcome [13,19–21]. The gene discussed is FOXM1; the disease is neoplasm.